Operating Income (Loss) in USD of HilleVax, Inc. from Q1 2021 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
HilleVax, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2021 to Q2 2025.
- HilleVax, Inc. Operating Income (Loss) for the quarter ending 30 Jun 2025 was -$6.99M, a 83.7% increase year-over-year.
- HilleVax, Inc. Operating Income (Loss) for the twelve months ending 30 Jun 2025 was -$77.1M, a 53.8% increase year-over-year.
- HilleVax, Inc. annual Operating Income (Loss) for 2024 was -$155M, a 16.5% decline from 2023.
- HilleVax, Inc. annual Operating Income (Loss) for 2023 was -$133M, a 105% decline from 2022.
- HilleVax, Inc. annual Operating Income (Loss) for 2022 was -$65.1M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)